Concepedia

Luca Faloppi

LF

Statistics

Publications

46

Citations

2K

H-Index

29

Active since

2010

Affiliations

Marche Polytechnic University(Current)

University of Cagliari

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Istituto Tumori Bari

Luca Faloppi is an author at Marche Polytechnic University specializing in oncology, medicine, and malignant neoplasms.

Publications per year

2010–2022

46

Publications

46

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study

Mario Scartozzi, Luca Faloppi, Gianluca Svegliati‐Baroni et al. · International Journal of Cancer · 2014 · 135 citations · Full text

Medicine, Genetics, Oncology +17

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

Mario Scartozzi, Riccardo Giampieri, Elena Maccaroni et al. · British Journal of Cancer · 2012 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

Luca Faloppi, Mario Scartozzi, Maristella Bianconi et al. · BMC Cancer · 2014 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

Andrea Casadei‐Gardini, Emanuela Scarpi, Luca Faloppi et al. · Oncotarget · 2016 · 94 citations · Full text

Medicine, Immunology, Oncology +17

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale

Andrea Casadei‐Gardini, Luca Faloppi, Serena De Matteis et al. · European Journal of Cancer · 2017 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–5 of 46